You are here

amycretin

Obesity pill race heats up as Novo, Roche and Terns share data

BioSpace

Tue, 09/17/24 - 11:22 am

Terns Pharmaceuticals

clinical trials

Novo Nordisk hails ‘remarkable’ weight loss result for dual-acting oral drug in early trial

Fierce Biotech

Wed, 09/11/24 - 11:53 am

clinical trials

Is Novo Nordisk on the Verge of Another Blockbuster Drug?

Motley Fool

Tue, 03/19/24 - 11:25 am

Novo Nordisk confident of amycretin obesity drug launch this decade

Reuters

Fri, 03/8/24 - 11:09 am

Novo valuation surpasses Tesla on experimental obesity drug data

Reuters

Thu, 03/7/24 - 11:40 am

clinical trials

Novo Nordisk R&D spend jumps 35% thanks to soaring sales as oral obesity plans advance

Fierce Biotech

Wed, 01/31/24 - 11:55 am